Impedance Measurements in Heart Failure Patients

Phase 1

Terminated

• Conditions: Heart Failure

• Registration Number: NCT01509495
• Lead Sponsor: Medtronic BRC

Brief Summary

The purpose of this study is to measure impedance during inpatient treatment.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-12
• Study First Submitted: 2011-12-07
• Study First Submitted QC: 2012-01-10
• Study First Posted: 2012-01-13
• Status Verified: 2014-05
• Primary Completion: 2014-05
• Study Completion: 2014-05
• Last Update Submitted: 2014-07-03
• Last Update Posted: 2014-07-04

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• patients admitted to hospital for symptoms of congestive heart failure
• patients older than 18 years
• patients willing and able to give informed consent

Exclusion Criteria

• patients who will require adrenergic or positive inotropic medications
• patients enrolled in a concurrent study that may confound the results of this study
• patients unable or unwilling to participate in study procedures
• patients who are pregnant
• patients who are mentally handicapped or legal incompetent
• patients who are dependent on investigator or sponsor

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Impedance Measurement of Patients in Heart Failure, impedance change first to last measurement	every 4 hours up to 48 hours

Secondary Outcome Measures

Name	Time	Method
Correlation between hemodynamic (central venous or arterial pressure) and impedance measurements (optional)	every 4 hours up to 48 hours
Accuracy of Respiratory rate determined by impedance measurements	every 4 hours up to 48 hours

Trial Locations

Locations (3)

Universitätsklinik Würzburg, Medizinische Klinik und Poliklinik I; 🇩🇪 Würzburg, Franken, Germany

Nemocnice Na Homolce; 🇨🇿 Praha, Czech Republic

NUSCH; 🇸🇰 Bratislava, Slovakia